Syndax Pharmaceuticals, Inc. SNDX
8.72 USD -0.41 (-4.49%)
Regular-session close
8.72 0.00 0.00%
After hours · Nov 20, 4:16 PM ET
8.69 Day range 9.27
8.56 52-week range 25.15
- YTD
- -58.50%
- 1 year
- -48.86%
News
benzinga.com UBS Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $31 UBS analyst David Dai maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and lowers the price target from $33 to $31.
seekingalpha.com Syndax Pharmaceuticals, Inc. (SNDX) Presents at UBS Global Biopharma Conference 2026 Transcript Syndax Pharmaceuticals, Inc. (SNDX) Presents at UBS Global Biopharma Conference 2026 Transcript
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Curis (NASDAQ:CRIS) shares moved upwards by 61.8% to $1.16 during Wednesday's regular session. The market value of their outstanding shares is at $1.7 million. Lyell Immunopharma…
benzinga.com Apple To $350? Here Are 10 Top Analyst Forecasts For Tuesday Analysts raised targets for TEM, TWLO, UPWK, MRSH and PLTR; cut MRVL and AAPL targets, with upgrades for TWLO and MRSH.benzinga.com HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $36 HC Wainwright & Co. analyst Andres Y. Maldonado maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and lowers the price target from $38 to $36.
benzinga.com Syndax Pharmaceuticals Q3 EPS $(0.55) Misses $(0.49) Estimate, Sales $83.298M Beat $81.850M Estimate Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.49) by 12.24 percent. This is a 21.43 percent increase over…
